I really don't want to be a doctor

Chapter 109 Accompanying You to the Library
After Luo Xin heard what Jing Xiaoran said, the expression on her face was astonished!

"Didn't he go to the laboratory every time after class?"

"Then do the experiment and go back to the dormitory very late?"

"How can he have time to study?"

Looking at Jing Xiaoran's figure on the podium, Luo Xin had a huge question in his heart.

We are all freshmen with the same start and all studying under the same roof, why is there such a big gap?
"Fortunately, he hasn't been able to publish a paper yet." Luo Xin comforted herself, "Publishing a paper is much more difficult than endorsing it."

After Jing Xiaoran finished speaking, he walked directly off the podium, and everyone looked at him with a trace of inexplicable admiration.

This is regional anatomy, one of the most difficult medical courses, it is really not easy for Jing Xiaoran to study it so deeply and analyze it clearly.

"Jing Xiaoran, maybe you spoke a little too fast just now." Shen Xiaorong said, "I see some students' expressions are a bit dazed. You have time to write down all these experiences and post them in the class group. I think it will be very helpful for everyone to learn anatomy." has an effect."

"Okay, Teacher Shen." Jing Xiaoran responded.

These experiences are all summed up by himself over the years, and they are not important things. Jing Xiaoran is not a person who cherishes himself, so he is happy to share them with everyone.

What's more, whether this kind of experience talk is useful to everyone is still a matter of opinion, after all, it is only applicable to Jing Xiaoran himself at present.

Next, a few students shared their memory methods, but most of them were similar to what Luo Xin said, and they were all generalities without any practical use.

"Squad leader, where do you study by yourself at night?"

After the regular meeting ended, Hong Sheng immediately ran to Jing Xiaoran's side.

"I've been studying in the library recently, what's the matter with you?" Jing Xiaoran packed his schoolbag, going to the cafeteria to finish dinner first, and then go to the library for self-study.

Jing Xiaoran is currently sorting out papers on "New Oral Anticoagulant Drugs". In addition to the previous one, he has also published several papers related to it, but the impact factors are very low, probably around 1-5.

Although the impact factors of the journals published by these articles are not high, the advantage lies in the large number, and Jing Xiaoran chooses high-quality journals, not the water journals that Chinese scholars like to publish.

"Then I'll go to the library with you to review." Hong Sheng thought for a while.

"Will you go to the library with me?"

Jing Xiaoran looked at Hong Sheng in surprise. On the surface, this person is not a student who loves to study!
And judging from the memory of his previous life, Hong Sheng's review time is related to the length of his death in the game.

Jing Xiaoran vaguely remembered that someone once broke the news about Hong Sheng's review method.

He was playing League of Legends while putting the textbook aside. When the game characters died and the computer screen turned black and white, it was time for him to review.

Why has Hong Sheng changed his temper now?

Could it be that he was overwhelmed by his "mighty and domineering" speech on the podium just now?
Hong Sheng secretly glanced around and found no one, said: "I heard that there are many girls in the library, but I haven't seen them before."

Jing Xiaoran: "..."

It seemed that I had a high opinion of Hong Sheng, thinking that he was shocked by what I said, and wanted to learn instead.

Unexpectedly, there is an unknown secret hidden behind the scumbag's hard work.

"Squad leader, please take me with you." Hong Sheng continued to chatter, "I now find that the library is a good place, a good place to cultivate one's sentiments, and you can study by the way. It's best not to fail at the end of the semester."

"You can do it yourself, think about it, if I'm here, it's not easy for you to act." Jing Xiaoran stopped, looked at Hong Shengyu and said earnestly, "You can go wherever you want by yourself."

"But I have never been to the library once." Hong Sheng gritted his teeth, "If I get lost, it will be difficult."

Jing Xiaoran: "..."

In the end, Hong Sheng followed Jing Xiaoran in a stern manner, as if he was the "binding equipment" picked up by Jing Xiaoran, and kept close to each other.

But with Hong Sheng as a follower, Jing Xiaoran felt a little less lonely along the way.

Come to the electronic reading room on the fourth floor of the library.

"I'll go to the electronic reading room to look up information. If you want to go... you can go up to the fifth floor." Jing Xiaoran thought for a while and said, "Cough...there are many girls there, so it may be more suitable for you."

Hong Sheng's eyes lit up when he heard the words, "Where is the fifth floor?"

"Of course it's the study room."

Generally speaking, there are more girls studying medicine than boys. For example, in Jing Xiaoran's class, there are about three-fifths of girls.

Girls are generally more hardworking and serious than boys, so most of the students in the study room are girls.

But having said that, in the medical field, when both men and women are under the same conditions, boys have a huge advantage. Whether it is in postgraduate entrance examination interviews, job interviews, internal medicine or surgery, all teachers or employers tend to favor boys.

Unless a girl is good enough, one or two grades higher than boys, then it is possible to compete with boys.

Therefore, for many girls studying medicine, they may pay much more than boys.

"Let me go to the electronic reading room with you first." Hong Sheng said, "I'll go to the fifth floor later."

"It's up to you." Jing Xiaoran smiled, and walked directly into the electronic reading room, followed by Hong Sheng carrying a black and white schoolbag.

There are computers equipped by the school in the electronic reading room, all of which are free to use the Internet, but the models of the computers are old and slow, unless some elective courses need to use the intranet, otherwise few people will use the computers here.

Jing Xiaoran took out his computer, connected to the wireless network in the electronic reading room, and logged in to his mailbox skillfully.

It has been almost two months since he submitted the manuscript, and the magazine should reply soon.

Sure enough, there was a new email.

Jing Xiaoran's mind tightened, and he opened it to look, I'll go, it's actually spam...

At the same time, on the far side of the ocean.

Inside the magazine "DRUG DISCOVERY TODAY" in the United States.

Dakman Barek is an editor-in-chief of this magazine. Compared with ordinary editors, the editor-in-chief decides whether an article can pass the final review.

The review process of general papers is divided into three steps. First, there will be a preliminary review by the editor. After passing the review, the paper will be sent to experts in the same industry for review, which is the so-called peer review.Finally, the experts will feed back the results of their review to the editor-in-chief, and the editor-in-chief will decide whether to accept the manuscript.

In addition to being the editor-in-chief of a magazine, Duckman is also a consultant to a pharmaceutical company.Although his reputation is not as good as those big names at the top of the medical pyramid, he is quite famous in American pharmaceutical companies.

The reason is that he is good at discovering all kinds of new drugs. It is important to know that every new drug that can be marketed will bring immeasurable profits to the new drug company.

However, the development cycle of a new drug is long and the cost is high, so many pharmaceutical companies prefer to directly buy some drugs that have completed the first or second phase of clinical trials.

However, the risks involved are not low. Even if a new drug has passed the second phase of clinical trials, it may not be able to be marketed. Even if it can be marketed, if there are too many side effects, it will still be recalled.

Dachman is a leader in this kind of "speculative" behavior. He has repeatedly purchased many new drugs in Phase I and Phase II clinical trials at low prices, earning a lot of money.

(End of this chapter)